{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:18:44Z","timestamp":1762521524468},"reference-count":18,"publisher":"The Society for Free Radical Research Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Biochem. Nutr."],"published-print":{"date-parts":[[2012]]},"DOI":"10.3164\/jcbn.12-15","type":"journal-article","created":{"date-parts":[[2012,6,19]],"date-time":"2012-06-19T22:43:25Z","timestamp":1340145805000},"page":"189-195","source":"Crossref","is-referenced-by-count":8,"title":["Strategies for peptic ulcer healing after 1 week proton pump inhibitor-based triple <i>Helicobacter pylori<\/i> eradication therapy in Japanese patients: differences of gastric ulcers and duodenal ulcers"],"prefix":"10.3164","volume":"51","author":[{"given":"Toshihisa","family":"Takeuchi","sequence":"first","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Umegaki","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nozomi","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukiko","family":"Yoda","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Kojima","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tokioka","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhide","family":"Higuchi","sequence":"additional","affiliation":[{"name":"2nd Department of Internal Medicine, Osaka Medical College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"OMC G&H research group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1739","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Bazzoli F, Zagari RM, Fossi S, et al. Short-term low-dose triple therapy for the eradication of Helicobacter pylori<\/i>. Eur J Gastroenterol Hepatol 1994; 6: 773–777.","DOI":"10.1097\/00042737-199409000-00004"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Lind T, Veldhuyzen van Zanten S, Unge P, et al. Eradication of Helicobacter pylori<\/i> using one-week triple therapies combining omeprazole with two antimicrobials: the MACH 1 Study. Helicobacter 1996; 1: 138–144.","DOI":"10.1111\/j.1523-5378.1996.tb00027.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Zanten SJ, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori<\/i> and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 289–295.","DOI":"10.1046\/j.1365-2036.1999.00471.x"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Malfertheiner P, Bayerdörffer E, Diete U, et al. The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori<\/i> infection in patients with gastric ulcer. Aliment Pharmacol Ther 1999; 13: 703–712.","DOI":"10.1046\/j.1365-2036.1999.00535.x"},{"key":"5","unstructured":"5 Goh KL, Navaratnam P, Peh SC, et al. Helicobacter pylori<\/i> eradication with short-term therapy leads to duodenal ulcer healing without the need for continued acid suppression therapy. Eur J Gastroenterol Hepatol 1996; 8: 421–423."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Hosking SW, Ling TK, Chung SC, et al. Duodenal ulcer healing by eradication of Helicobacter pylori<\/i> without anti-acid treatment: randomized controlled trial. Lancet 1994; 343: 508–510.","DOI":"10.1016\/S0140-6736(94)91460-5"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Lam SK, Ching CK, Lai KC, et al. Does treatment of Helicobacter pylori<\/i> with antibiotics alone heal duodenal ulcer? A randomized double blind placebo controlled study. Gut 1997; 41: 43–48.","DOI":"10.1136\/gut.41.1.43"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Ge ZZ, Zhang DZ, Xiao SD, Chen Y, Hu YB. Does eradication of Helicobacter pylori<\/i> alone heal duodenal ulcers? Aliment Pharmacol Ther 2000; 14: 53–58.","DOI":"10.1046\/j.1365-2036.2000.00673.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Zanten SJ, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori<\/i> and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy. Aliment Pharmacol Ther 1999; 13: 289–295.","DOI":"10.1046\/j.1365-2036.1999.00471.x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Higuchi K, Fujiwara Y, Tominaga K, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori<\/i>? A randomized, controlled, prospective study. Aliment Pharmacol Ther 2003; 17: 111–117.","DOI":"10.1046\/j.1365-2036.2003.01402.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Terano A, Arakawa T, Sugiyama T, et al. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori<\/i> in a Japanese population: a randomized, double-blind, placebo-controlled trial. J Gastroenterol 2007; 42: 690–693.","DOI":"10.1007\/s00535-007-2076-2"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Hiraishi H, Haruma K, Miwa H, Goto H. Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori<\/i> infection—the results of a multicenter, double-blind, randomized clinical trial (IMPACT study). Aliment Pharmacol Ther 2010; 31: 824–833.","DOI":"10.1111\/j.1365-2036.2010.04250.x"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Murakami K, Okimoto T, Kodama M, et al. Comparison of the efficacy of irsogladine maleate and famotidine for the healing of gastric ulcers after Helicobacter pylori<\/i> eradication therapy: a randomized, controlled, prospective study. Scand J Gastroenterol 2011; 46: 287–292.","DOI":"10.3109\/00365521.2010.531485"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Higuchi K, Watanabe T, Tanigawa T, Tominaga K, Fujiwara Y, Arakawa T. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori<\/i>: a randomized controlled comparative trial with cimetidine, an H2<\/sub>-receptor antagonist. J Gastroenterol Hepatol 2010; 25 (Suppl 1): S155–S160.","DOI":"10.1111\/j.1440-1746.2010.06232.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Laheij RJ, Van Ijzendoorn MC, Janssen MJ, Jansen JB. Gastric acid-suppressive therapy and community-acquired respiratory infections. Aliment Pharmacol Ther 2003; 18: 847–851.","DOI":"10.1046\/j.1365-2036.2003.01744.x"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Yang YX, Lewis JD, Epstein S, Metz DC. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 2006; 296: 2947–2953.","DOI":"10.1001\/jama.296.24.2947"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Laheij RJ, Sturkenboom MC, Hassing RJ, Dieleman J, Stricker BH, Jansen JB. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004; 292: 1955–1960.","DOI":"10.1001\/jama.292.16.1955"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Juurlink DN, Gomes T, Ko DT, et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009; 180: 713–718.","DOI":"10.1503\/cmaj.082001"}],"container-title":["Journal of Clinical Biochemistry and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/51\/3\/51_12-15\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T04:09:25Z","timestamp":1561867765000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jcbn\/51\/3\/51_12-15\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.3164\/jcbn.12-15","relation":{},"ISSN":["0912-0009","1880-5086"],"issn-type":[{"type":"print","value":"0912-0009"},{"type":"electronic","value":"1880-5086"}],"subject":[],"published":{"date-parts":[[2012]]}}}